Data: elevated CRP levels predict AMD risk

September 1, 2004

Fort Lauderdale, FL-Results of analyses of data collected in an ancillary study of the Age-Related Eye Disease Study (AREDS) demonstrate that an elevated level of C-reactive protein (CRP), a marker of systemic inflammation, is an independent risk factor for age-related macular degeneration (AMD). That finding provides further support for the concept that inflammation is involved in AMD pathogenesis, said Johanna M. Seddon, MD, principal investigator of the study, at the annual meeting of the Association for Research in Vision and Ophthalmology.